Literature DB >> 11179021

Familial dysautonomia is caused by mutations of the IKAP gene.

S L Anderson1, R Coli, I W Daly, E A Kichula, M J Rork, S A Volpi, J Ekstein, B Y Rubin.   

Abstract

The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded identification. We identified and characterized the RNAs encoded by this region of chromosome 9 in cell lines derived from individuals homozygous for the major FD haplotype, and we observed that the RNA encoding the IkappaB kinase complex-associated protein (IKAP) lacks exon 20 and, as a result of a frameshift, encodes a truncated protein. Sequence analysis reveals a T-->C transition in the donor splice site of intron 20. In individuals bearing a minor FD haplotype, a missense mutation in exon 19 disrupts a consensus serine/threonine kinase phosphorylation site. This mutation results in defective phosphorylation of IKAP. These mutations were observed to be present in a random sample of Ashkenazi Jewish individuals, at approximately the predicted carrier frequency of FD. These findings demonstrate that mutations in the gene encoding IKAP are responsible for FD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179021      PMCID: PMC1274486          DOI: 10.1086/318808

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  11 in total

1.  Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature.

Authors:  P W Brunt; V A McKusick
Journal:  Medicine (Baltimore)       Date:  1970-09       Impact factor: 1.889

2.  Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31.

Authors:  A Blumenfeld; S A Slaugenhaupt; C B Liebert; V Temper; C Maayan; S Gill; D E Lucente; M Idelson; K MacCormack; M A Monahan; J Mull; M Leyne; M Mendillo; T Schiripo; E Mishori; X Breakefield; F B Axelrod; J F Gusella
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

3.  Characterization of IKI1 and IKI3 genes conferring pGKL killer sensitivity on Saccharomyces cerevisiae.

Authors:  H Yajima; M Tokunaga; A Nakayama-Murayama; F Hishinuma
Journal:  Biosci Biotechnol Biochem       Date:  1997-04       Impact factor: 2.043

Review 4.  Familial dysautonomia: diagnosis, pathogenesis and management.

Authors:  F B Axelrod; R Nachtigal; J Dancis
Journal:  Adv Pediatr       Date:  1974

5.  The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.

Authors:  D Krappmann; E N Hatada; S Tegethoff; J Li; A Klippel; K Giese; P A Baeuerle; C Scheidereit
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

6.  Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation.

Authors:  G Otero; J Fellows; Y Li; T de Bizemont; A M Dirac; C M Gustafsson; H Erdjument-Bromage; P Tempst; J Q Svejstrup
Journal:  Mol Cell       Date:  1999-01       Impact factor: 17.970

7.  DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia.

Authors:  X O Breakefield; L Ozelius; M A Bothwell; M V Chao; F Axelrod; P L Kramer; K K Kidd; A A Lanahan; D E Johnson; A H Ross
Journal:  Mol Biol Med       Date:  1986-12

8.  Structural gene for beta-nerve growth factor not defective in familial dysautonomia.

Authors:  X O Breakefield; G Orloff; C Castiglione; L Coussens; F B Axelrod; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Tumor necrosis factor and IFN induce a common set of proteins.

Authors:  B Y Rubin; S L Anderson; R M Lunn; N K Richardson; G R Hellermann; L J Smith; L J Old
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

10.  IKAP is a scaffold protein of the IkappaB kinase complex.

Authors:  L Cohen; W J Henzel; P A Baeuerle
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

View more
  163 in total

1.  Afferent baroreflex failure in familial dysautonomia.

Authors:  Lucy Norcliffe-Kaufmann; Felicia Axelrod; Horacio Kaufmann
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

2.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

3.  Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene.

Authors:  Sylvia L Anderson; Josef Ekstein; Mary C Donnelly; Erin M Keefe; Nicole R Toto; Lauretta A LeVoci; Berish Y Rubin
Journal:  Hum Genet       Date:  2004-06-23       Impact factor: 4.132

4.  The Elongator subcomplex Elp456 is a hexameric RecA-like ATPase.

Authors:  Sebastian Glatt; Juliette Létoquart; Céline Faux; Nicholas M I Taylor; Bertrand Séraphin; Christoph W Müller
Journal:  Nat Struct Mol Biol       Date:  2012-02-19       Impact factor: 15.369

Review 5.  tRNA biology charges to the front.

Authors:  Eric M Phizicky; Anita K Hopper
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

Review 6.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

7.  Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4).

Authors:  Lisa J Strug; Tara Clarke; Theodore Chiang; Minchen Chien; Zeynep Baskurt; Weili Li; Ruslan Dorfman; Bhavna Bali; Elaine Wirrell; Steven L Kugler; David E Mandelbaum; Steven M Wolf; Patricia McGoldrick; Huntley Hardison; Edward J Novotny; Jingyue Ju; David A Greenberg; James J Russo; Deb K Pal
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

8.  Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.

Authors:  Lin Li; Katherine Gruner; Warren G Tourtellotte
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 9.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

Review 10.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.